Cargando…
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
The unique metabolism of most solid tumours (aerobic glycolysis, i.e., Warburg effect) is not only the basis of diagnosing cancer with metabolic imaging but might also be associated with the resistance to apoptosis that characterises cancer. The glycolytic phenotype in cancer appears to be the commo...
Autores principales: | Michelakis, E D, Webster, L, Mackey, J R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567082/ https://www.ncbi.nlm.nih.gov/pubmed/18766181 http://dx.doi.org/10.1038/sj.bjc.6604554 |
Ejemplares similares
-
Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
por: Tataranni, Tiziana, et al.
Publicado: (2019) -
Mito-DCA: A Mitochondria Targeted Molecular Scaffold
for Efficacious Delivery of Metabolic Modulator Dichloroacetate
por: Pathak, Rakesh K., et al.
Publicado: (2014) -
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016) -
Targeting glucose metabolism for cancer therapy
por: Hamanaka, Robert B., et al.
Publicado: (2012) -
Anaerobic Microbial Metabolism of Dichloroacetate
por: Chen, Gao, et al.
Publicado: (2021)